Polycyclic aromatic compound
US-2020190115-A1 · Jun 18, 2020 · US
US12356853B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12356853-B2 |
| Application number | US-202418610157-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 19, 2024 |
| Priority date | Jul 15, 2020 |
| Publication date | Jul 8, 2025 |
| Grant date | Jul 8, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a light-emitting device including a condensed cyclic compound represented by Formula 1 and an electronic apparatus including the light-emitting device, where Formula 1 is the same as described in the present specification. The light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode, and emission layer including at least one of the condensed cyclic compound represented by Formula 1.
Opening claim text (preview).
What is claimed is: 1. A condensed cyclic compound represented by Formula 1: wherein, in Formula 1, ring A 1 to ring A 4 are each independently a C 5 -C 30 carbocyclic group or a C 2 -C 30 heterocyclic group, X 1 is O, S, Se, C(R 1a )(R 1b ), Si(R 1a )(R 1b ), or N(R 1a ), X 2 is O, S, Se, C(R 2a )(R 2b ), Si(R 2a )(R 2b ), or N(R 2a ), X 3 is O, S, Se, C(R 3a )(R 3b ), Si(R 3a )(R 3b ), or N(R 3a ), X 4 is O, S, Se, C(R 4a )(R 4b ), Si(R 4a )(R 4b ), or N(R 4a ), Y 1 and Y 2 are each independently B, P(═O), or P(═S), R 1 to R 4 , R 1a to R 4a , and R 1b to R 4b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ), d1 to d4 are each independently an integer in a range from 1 to 20, and two or more groups selected from R 1 to R 4 , R 1a to R 4a , and R 1b to R 4b are optionally linked together to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a or a C 2 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a , and R 10a is: deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof; a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —C 1 , —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof. 2. The condensed cyclic compound of claim 1 , wherein ring A 1 to ring A 4 are each independently a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, cyclopentadiene group, a 1,2,3,4-tetrahydronaphthalene group, a thiophene group, a furan group, an indole group, a benzoborole group, a benzophosphole group, an indene group, a benzosilole group, a benzogermole group, a benzothiophene group, a benzoselenophene group, a benzofuran group, a carbazole group, a dibenzoborole group, a dibenzophosphole group, a fluorene group, a dibenzosilole group, a dibenzogermole group, a dibenzothiophene group, a dibenzoselenophene group, a dibenzofuran group, a dibenzothiophene 5-oxide group, 9H-fluorene-9-one group, a dibenzothiophene 5,5-dioxide group, an azaindole group, an azabenzoborole group, an azabenzophosphole group, an azaindene group, an azabenzosilole group, an azabenzogermole group, an azabenzothiophene group, an azabenzoselenophene group, an azabenzofuran group, an azacarbazole group, an azadibenzoborole group, an azadibenzophosphole group, an azafluorene group, an azadibenzosilole group, an azadibenzogermole group, an azadibenzothiophene group, an azadibenzoselenophene group, an azadibenzofuran group, an azadibenzothiophene 5-oxide group, an aza-9H-fluorene-9-one group, an azadibenzothiophene 5,5-dioxide group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isooxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, or a 5,6,7,8-tetrahydroquinoline group. 3. The condensed cyclic compound of claim 1 , wherein ring A 1 to ring A 4 are each independently a benzene group, a naphthalene group, a carbazole group, a fluorene group, a dibenzothiophene group, or a dibenzofuran group. 4. The condensed cyclic compound of claim 1 , wherein X 3 is N(R 3a ) or O. 5. The condensed cyclic compound of claim 1 , wherein: (i) X 1 is O, X 2 is O, X 3 is O, and X 4 is O; (ii) X 1 is O, X 2 is O, X 3 is N(R 3a ), and X 4 is O; (iii) X 1 is N(R 1a ), X 2 is O, X 3 is O, and X 4 is O; (iv) X 1 is N(R 1a ), X 2 is O, X 3 is N(R 3a ), and X 4 is O; (v) X 1 is O, X 2 is N(R 2a ), X 3 is N(R 3a ), and X 4 is O; (vi) X 1 is O, X 2 is O, X 3 is N(R 3a ), and X 4 is N(R 4a ); (vii) X 1 is S, X 2 is O, X 3 is N(R 3a ), and X 4 is O; (viii) X 1 is S, X 2 is S, X 3 is N(R 3a ), and X 4 is N(R 4a ); (ix) X 1 is N(R 1a ), X 2 is N(R 2a ), X 3 is N(R 3a ), and X 4 is O; (x) X 1 is N(R 1a ), X 2 is O, X 3 is N(R 3a ), and X 4 is N(R 4a ); (xi) X 1 is N(R 1a ), X 2 is S, X 3 is N(R 3a ), and X 4 is N(R 4a ); or (xii) X 1 is N(R 1a ), X 2 is N(R 2a ), X 3 is N(R 3a ), and X 4 is N(R 4a ). 6. The condensed cyclic compound of claim 1 , wherein Y 1 and Y 2 are each independently B. 7. The condensed cyclic compound of claim 1 , wherein R 1 to R 4 , R 1a to R 4a , and R 1b to R 4b are each independently selected from: hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 20 alkyl group, and a C 1 -C 20 alkoxy group; a C 1 -C 20 alkyl group and a C 1 -C 20 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro g
Organoboranes · CPC title
Organic materials used in the body or electrodes of devices covered by this subclass · CPC title
Wavelength conversion means · CPC title
Electron injection layers · CPC title
Carrier blocking layers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.